LOGIN  |  REGISTER
Amneal Pharmaceuticals
Compass Therapeutics

Addus HomeCare to Participate in Upcoming Investor Conferences in May

May 06, 2025 | Last Trade: US$108.24 10.20 10.40

FRISCO, Texas / May 06, 2025 / Business Wire / Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced its participation at the following investor conferences in May:

  • BofA Securities 2025 Health Care Conference in Las Vegas, Nevada, on Wednesday, May 14, 2025. Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will present at 9:20 a.m. Pacific Time / 11:20 a.m. Central Time on Wednesday, May 14, 2025.
  • 2025 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 20, 2025. Dirk Allison, Chairman and Chief Executive Officer and Brian Poff, Executive Vice President and Chief Financial Officer will present at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on Tuesday, May 20, 2025.

In connection with the virtual conferences, there will be a live broadcast and replay of the Company’s presentation available under the Investor Relations section of the Company’s website, www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately one hour following the conclusion of the live broadcast.

About Addus HomeCare

Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to approximately 62,000 consumers through 260 locations across 23 states. For more information, please visit www.addus.com.

Chimerix

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page